IMCIVREE™ (setmelanotide)
www.imcivree.com
www.imcivree.com
IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long term by reducing hunger and food intake and increasing energy expenditure in those with Bardet-Biedl syndrome (BBS), pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency obesity in adult and pediatric patients 2 years of age and older.